PMC:7461420 / 51447-51581
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T231","span":{"begin":77,"end":81},"obj":"Body_part"}],"attributes":[{"id":"A231","pred":"fma_id","subj":"T231","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Furthermore, the group observed high antiviral activity of both compounds in cell‐based assays (61: EC50, 0.42 µM; 62: EC50, 0.33 µM)."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T651","span":{"begin":47,"end":55},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T652","span":{"begin":77,"end":81},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"Furthermore, the group observed high antiviral activity of both compounds in cell‐based assays (61: EC50, 0.42 µM; 62: EC50, 0.33 µM)."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T43475","span":{"begin":17,"end":22},"obj":"Chemical"},{"id":"T3504","span":{"begin":37,"end":46},"obj":"Chemical"}],"attributes":[{"id":"A35307","pred":"chebi_id","subj":"T43475","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A14597","pred":"chebi_id","subj":"T3504","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"}],"text":"Furthermore, the group observed high antiviral activity of both compounds in cell‐based assays (61: EC50, 0.42 µM; 62: EC50, 0.33 µM)."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T456","span":{"begin":0,"end":134},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Furthermore, the group observed high antiviral activity of both compounds in cell‐based assays (61: EC50, 0.42 µM; 62: EC50, 0.33 µM)."}